ADC Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates

[ad_1] 2Q 2023 ZYNLONTA®1 net sales increased 11% year-over-year; Implemented new go-to-market strategy during the quarter to support growth Operating expenses decreased 20%2 year-over-year due to portfolio prioritization and organizational efficiencies…

Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas at European Hematology Association (EHA) Annual Meeting 2023

[ad_1] We recognize you are attempting to access this website from a country belonging to the European Economic Area (EEA) including the EU which enforces the General Data Protection Regulation…

Clinical Study Result of Orelabrutinib in Patients with R/R MCL Published by Blood Advances

[ad_1] Clinical Study Result of Orelabrutinib in Patients with R/R MCL …  WV News [ad_2] Source link